← Back to Discover
Kalehua Capital Management LLC
Period ended Sep 30, 2026 · Latest filing Nov 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $132,396,155
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- VERADERMICS INC · COMMON STOCK · 922967104 · shares: $17,662,605
- EA SERIES TRUST · ALPHA ARCH 1-3 · 02072L565 · shares: $17,577,482
- KORSANA BIOSCIENCES INC · COM · 23255M303 · shares: $14,164,896
- X4 PHARMACEUTICALS INC · COM NEW · 98420X202 · shares: $10,796,236
- ACLARIS THERAPEUTICS INC · COM · 00461U105 · shares: $9,638,240
- SURROZEN INC · COM NEW · 86889P208 · shares: $9,206,441
- INHIBIKASE THERAPEUTICS INC · COM NEW · 45719W205 · shares: $7,853,984
- SEPTERNA INC · COM · 81734D104 · shares: $7,612,507
- BETTERLIFE PHARMA INC · COM · 08772P202 · shares: $6,675,339
- OBSIDIAN THERAPEUTICS INC · COM · 67448A106 · shares: $5,720,591
Reported holdings
22 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 145,695 shares | $17,662,605 |
| EA SERIES TRUST | ALPHA ARCH 1-3 | 02072L565 | — | 148,471 shares | $17,577,482 |
| KORSANA BIOSCIENCES INC | COM | 23255M303 | — | 442,653 shares | $14,164,896 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 3,722,840 shares | $10,796,236 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 1,832,365 shares | $9,638,240 |
| SURROZEN INC | COM NEW | 86889P208 | — | 286,092 shares | $9,206,441 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 3,821,890 shares | $7,853,984 |
| SEPTERNA INC | COM | 81734D104 | — | 194,544 shares | $7,612,507 |
| BETTERLIFE PHARMA INC | COM | 08772P202 | — | 27,710,000 shares | $6,675,339 |
| OBSIDIAN THERAPEUTICS INC | COM | 67448A106 | — | 416,649 shares | $5,720,591 |
| INFLARX NV | COM | N44821101 | — | 2,921,095 shares | $5,257,971 |
| KORRO BIO, INC | COM | 500946108 | — | 473,595 shares | $4,693,326 |
| ATTOVIA THERAPEUTICS INC | COM | 04987L102 | — | 200,000 shares | $3,428,000 |
| DAMORA THERAPEUTICS INC | COM NEW | G2646Y104 | — | 139,000 shares | $2,957,920 |
| UNIQURE NV | SHS | N90064101 | — | 79,407 shares | $1,918,473 |
| GOSSAMER BIO INC | COM | 38341P201 | — | 139,366 shares | $1,651,487 |
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | — | 1,651,258 shares | $1,429,494 |
| LEONABIO INC | COM | 04746L203 | — | 393,701 shares | $1,405,513 |
| ATRIUM THERAPEUTICS INC | COM | 04965N104 | — | 112,652 shares | $932,759 |
| INSTIL BIO INC | COM NEW | 45783C200 | — | 99,600 shares | $721,104 |
| ATYR PHARMA INC | COM NEW | 002120202 | — | 1,829,513 shares | $554,342 |
| KAZIA THERAPEUTICS LTD | SPONSORED ADS | 48669G303 | — | 56,013 shares | $537,445 |